Skip to content

Robotic Assisted Surgery In Total Knee Replacement

Robotic Assisted Surgery In Total Knee Replacement Versus Manual Total Knee Arthroplasty: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05842538
Enrollment
200
Registered
2023-05-06
Start date
2023-04-01
Completion date
2027-11-01
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The goal of this clinical trial is to compare robotic arm assisted surgery with manual surgery in patients operated with knee replacement. The main aim of the study is to compare changes in joint awareness (measured by the Forgotten Joint Score. Participants who are listed for knee arthroplasty are randomised to either robotic arm assisted surgery or manual surgery.

Detailed description

Study Title: Robotic Assisted Surgery in total knee replacement versus Manual Total Knee Arthroplasty: A randomised controlled trial Type of study: CE marked device study Trial Design: Multi-center site prospective parallel group randomised controlled trial Trial Participants: Listed for routine primary total knee replacements Investigational Device: MAKO Robotic Arm Assisted Surgical System Control: Conventional jig-based surgery Implant (Intervention and Control): Triathlon TKR Planned Sample Size: 200 (100 MAKO, 100 Manual) Follow-up duration: 24 months following surgery Planned Trial Period: Nov 2022 - 2024 Primary Objective: To compare changes in joint awareness (measured by the Forgotten Joint Score (FJS)20) from baseline to 12 months following TKR between the two groups. Secondary Objectives 1. To compare pain measured using the pain visual analogue scale. 2. To compare the health-related quality of life using the EQ5D-3L at baseline, 3, 12 and 24 months. 3. To compare changes in knee function in activities of daily living (measured by the Oxford knee score (OKS)19) from baseline to 3, 12 and 24 months. 4. To compare changes in clinically assessed pain and stiffness (measured by the Knee Society Score (KSS)) at baseline to 3 and 12 months. 5. To compare revision rate using implant migration measured by CTMA at 12 and 24 months as a surrogate marker for revision. Primary Endpoint: Functional outcome measured by the changes in joint awareness of the FJS score at 12 months following the intervention. Secondary Endpoints: Secondary outcomes will be collected up to 24 months following the intervention. Device Name: Both arms will receive Triathlon TKR with a highly crossed linked (X3) cruciate retaining polyethylene insert. The intervention group will utilise the MAKO robotic arm to make the bone cuts.

Interventions

DEVICETriathlon

Total knee arthroplasty

Sponsors

Stryker Nordic
CollaboratorINDUSTRY
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Listed for elective primary TKR for end stage osteoarthritis * Suitable candidate for a cruciate retaining TKR (Triathlon prosthesis) * Male or Female, aged 18 years or above (18-80 at the time of listing for surgery). * Able to understand and provide written consent.

Exclusion criteria

* Varus deformity of \> 20 degrees observed by consultant on examination * Patient is unable to comply with the study protocol (incl. refusal for CT scan) * Female participant who is pregnant, lactating or planning pregnancy during the course of the study. * Requires patella resurfacing * Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons * Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Forgotten Joint Score1 yearPatient-reported outcome

Secondary

MeasureTime frameDescription
Oxford Knee Score3, 12, 24 monthsPatient-reported outcome
Knee Society Score3, 12, 24 monthsPhysician-reported outcome
Knee pain2 yearsPatient-reported outcome
EQ-5D3, 12, 24 monthsPatient-reported outcome

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026